On another front, adaptive resistance is generated by IFN-γ-induced PD-L1 expression on either tumor cells themselves or on immune cells (macrophages, myeloid suppressor cells, dendritic cells, or even lymphocytes) in the tumor microenvironment. The gene discussed is IFNG; the disease is neoplasm.